Co-Diagnostics readies coronavirus test; shares rocket 181% premarket 
 Thinly traded nano cap Co-Diagnostics (NASDAQ:CODX) jumpsÂ  premarket on increased volume in reaction to its announcement that it has completed the principle design work for a PCR screening test for the coronavirus, 2019-nCoV, driving the current outbreak in China.

There has been only one confirmed case in the U.S. so far, a man in the Seattle area.